X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Aventis Pharma Fact Sheet, Aventis Pharma Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aventis Pharma Fact Sheet   (HOCM)

Here is the latest financial fact sheet of Aventis Pharma. For more details, see the Aventis Pharma quarterly results and Aventis Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SANOFI INDIA Price History

Price Rs 4,189.5
Mkt Cap Rs m 96,483
Vol '000 0.2
P/E X 31.5
P/CF X 22.5
EPS (TTM) Rs 133.1
% ch % -0.5
No. of shares m 23.03
% ch week % 0.2
% ch 1-mth % -1.3
% ch 12-mth % -6.6
52 week H/L Rs 4,930.0/3,990.0
(As on Jul 20, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SANOFI INDIA Financials

No. of Mths
Year Ending
12
Dec-12
12
Dec-13
12
Dec-14
12
Dec-15
12
Dec-16
5-Yr Chart
Click to enlarge
SANOFI INDIA EQUITY SHARE DATA
High Rs2,3992,8623,8004,5214,560 
Low Rs2,1962,4502,5003,4454,400 
Sales per share (Unadj.) Rs683.0785.4858.7952.31,028.5 
Earnings per share (Unadj.) Rs76.7115.1114.5139.6129.0 
Diluted earnings per shareRs76.7115.1114.5139.6129.0 
Cash flow per share (Unadj.) Rs115.7155.2156.4188.7186.0 
Dividends per share (Unadj.) Rs33.0045.0045.0065.0068.00 
Adj. dividends per shareRs33.0045.0045.0065.0068.00 
Dividend yield (eoy) %1.41.71.41.61.5 
Book value per share (Unadj.) Rs522.8584.8645.2706.5753.6 
Adj. book value per shareRs522.8584.8645.2706.5753.6 
Shares outstanding (eoy) m23.0323.0323.0323.0323.03 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.43.43.74.24.4 
Avg P/E ratio x30.023.127.528.534.7 
P/CF ratio (eoy) x19.917.120.121.124.1 
Price / Book Value ratio x4.44.54.95.65.9 
Dividend payout %43.039.139.346.652.7 
Avg Mkt Cap Rs m52,91161,16872,54591,724103,174 
No. of employees `0003.23.33.43.73.6 
Total wages/salary Rs m2,1382,4212,8823,3333,592 
Avg. sales/employee Rs Th4,971.75,496.45,735.25,987.06,537.7 
Avg. wages/employee Rs Th675.7735.7836.0909.9991.4 
Avg. net profit/employee Rs Th558.3805.8764.5877.7819.8 
SANOFI INDIA INCOME DATA
Net Sales Rs m15,73018,08919,77521,93023,686 
Other income Rs m412579643514708 
Total revenues Rs m16,14218,66720,41822,44424,394 
Gross profit Rs m3,1183,9793,3894,5915,281 
Depreciation Rs m8999239661,1301,313 
Interest Rs m1445415 
Profit before tax Rs m2,6173,6313,0613,9704,661 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m02546668390 
Tax Rs m8511,2331,0901,5941,691 
Profit after tax Rs m1,7672,6522,6363,2152,970 
Gross profit margin %19.822.017.120.922.3 
Effective tax rate %32.534.035.640.136.3 
Net profit margin %11.214.713.314.712.5 
SANOFI INDIA BALANCE SHEET DATA
Current assets Rs m8,2879,47112,62812,43715,673 
Current liabilities Rs m3,8664,6896,5586,1706,678 
Net working cap to sales %28.126.430.728.638.0 
Current ratio x2.12.01.92.02.3 
Inventory Days Days6369888076 
Debtors Days Days2324212422 
Net fixed assets Rs m7,4288,3488,5828,7718,098 
Share capital Rs m230230230230230 
"Free" reserves Rs m11,66513,09914,55916,00417,088 
Net worth Rs m12,04113,46714,85816,27217,356 
Long term debt Rs m00000 
Total assets Rs m16,31318,78322,27624,04625,400 
Interest coverage x187.9865.5638.6993.5311.7 
Debt to equity ratio x00000 
Sales to assets ratio x1.01.00.90.90.9 
Return on assets %10.914.111.913.411.8 
Return on equity %14.719.717.719.817.1 
Return on capital %21.928.925.129.626.9 
Exports to sales %15.623.024.224.224.5 
Imports to sales %27.530.236.926.128.0 
Exports (fob) Rs m2,4474,1524,7885,3125,801 
Imports (cif) Rs m4,3265,4557,2985,7206,627 
Fx inflow Rs m3,2034,8655,4956,6807,145 
Fx outflow Rs m4,8656,0948,0456,5876,846 
Net fx Rs m-1,662-1,229-2,55093299 
SANOFI INDIA CASH FLOW
From Operations Rs m 2,898 2,726 2,650 2,132 3,226 
From Investments Rs m -54 -3,354 613 359 -1,555 
From Financial Activity Rs m -897 -1,050 -1,217 -1,470 -1,818 
Net Cashflow Rs m 1,946 -1,678 2,046 1,021 -147 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 60.4%
Indian inst/Mut Fund 14.4%
FIIs 14.6%
ADR/GDR 0.0%
Free float 10.5%
Shareholders 15,184
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Aventis House, 54/A, Mathuradas Vasanji Road, Andheri (E), Mumbai-93
E-MAIL k.subramani@sanofi.com WEB www.sanofiindialtd.com
TELEPHONE (022) 2827 8000 FAX (022) 2837 0939
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR S. R. Batliboi & Co.
CHM: Vijay Mallya COMP SEC: K. Subramani YEAR OF INC: 1956 BSE CODE: 500674 FV (Rs): 10 DIV YIELD (%): 1.6

More Pharmaceuticals Company Fact Sheets:   DR. REDDYS LAB  CADILA HEALTHCARE  WYETH LTD  GLENMARK PHARMA  BIOCON LTD  

Compare SANOFI INDIA With:   DR. REDDYS LAB  CADILA HEALTHCARE  WYETH LTD  GLENMARK PHARMA  BIOCON LTD  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Mindtree Slumps Over 4%(Closing)

Indian share markets lost their growing momentum and finished marginally lower in the afternoon session. At the closing bell, the BSE Sensex stood lower by 51 points.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

Kaun Banega Crorepati(Daily Profit Hunter)

Jul 7, 2017

Read this if you want to win game shows or stock markets. The odds are the same.

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

Warren Buffett's Long Term Returns Immune to Volatility(Chart Of The Day)

Jul 8, 2017

Buffett's periodic underperformance to index fund.

More

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANOFI INDIA

SANOFI INDIA - WYETH LTD COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS